FDA Inspection
Sanofi Winthrop IndustrieSanofi Winthrop Industrie – FDA Inspection, Jul 25, 2017
Record Details
This FDA Inspection record concerns Sanofi Winthrop Industrie, with an inspection on July 25, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · cad42f47-1aad-4e97-912d-f854d2ceb564
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1022342
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Sanofi Winthrop Industrie
7| Date | Classification | Office | Project area |
|---|---|---|---|
| March 10, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 29, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 17, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 14, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 25, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sanofi Winthrop Industrie
- FDA Inspection 1246180 - 2023-03-10
- FDA Inspection 1118089 - 2019-03-29
- FDA Inspection 1063584 - 2018-07-17
- FDA Inspection 998080 - 2016-09-14
- FDA Inspection 857683 - 2013-10-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.